Literature DB >> 19666936

Combination therapy with ciclosporin and etanercept in patients with psoriatic arthritis.

Salvatore D'Angelo, Maria Stefania Cutro, Ennio Lubrano, Pietro Leccese, Gianna Angela Mennillo, Nicola Ferrara, Ignazio Olivieri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19666936     DOI： 10.1136/ard.2009.119446

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  6 in total

Review 1.  A dermatologist guide to immunogenicity.

Authors:  Collin M Blattner; Soham P Chaudhari; John Young; Jenny E Murase
Journal:  Int J Womens Dermatol       Date:  2016-07-18

2.  Psoriatic arthritis: is it time to treat-to-target or target to treat?

Authors:  Ennio Lubrano; Fabio Massimo Perrotta
Journal:  Clin Rheumatol       Date:  2017-10-24       Impact factor: 2.980

3.  Pharmacoeconomic burden in the treatment of psoriatic arthritis: from systematic reviews to real clinical practice studies.

Authors:  Ennio Lubrano; Antonio Spadaro
Journal:  BMC Musculoskelet Disord       Date:  2014-01-20       Impact factor: 2.362

Review 4.  Long term efficacy and safety of etanercept in the treatment of psoriasis and psoriatic arthritis.

Authors:  Dario Kivelevitch; Bobbak Mansouri; Alan Menter
Journal:  Biologics       Date:  2014-04-17

Review 5.  The Use of Cyclosporine A in Rheumatology: a 2016 Comprehensive Review.

Authors:  Cecilia Beatrice Chighizola; Voon H Ong; Pier Luigi Meroni
Journal:  Clin Rev Allergy Immunol       Date:  2017-06       Impact factor: 10.817

Review 6.  Cyclosporine regimens in plaque psoriasis: an overview with special emphasis on dose, duration, and old and new treatment approaches.

Authors:  M D Colombo; N Cassano; G Bellia; G A Vena
Journal:  ScientificWorldJournal       Date:  2013-07-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.